Validation of New Biomarkers for Predicting No-Reflow in STEMI Patients Undergoing Primary PCI

NCT07132489 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

114

Enrollment

OTHER

Sponsor class

Conditions

Myocardial Infarction
No Reflow Phenomenon

Interventions

DIAGNOSTIC_TEST: HbA1c/C-peptide ratio Albumin-bilirubin (ALBI) score. Neutrophil/HDL ratio

Sponsor

Assiut University